The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
Clinical trial NCT04803994 · RECRUITING
Trial details
- NCT number
- NCT04803994
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-06
- Primary completion
- 2027-07-01
- Enrollment
- 434
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.